SBI Capital Markets Ltd
Public issue of [*] equity shares of Rs. 10/- each of Advanced Enzyme Technologies Limited (The Company or the Issuer) for cash at a price of per equity share (including a premium of per equity share) aggregating upto Rs. [*] crores (The issue) comprising of a fresh issue of equity shares by our company aggregating to Rs. 200.00 crores (The Fresh Issue) and an offer for sale upto 37,00,000 equity shares by Mr. Vasant Laxminarayan Rathi, Mr. Pradip Bhailal Shah, Chandrakant Rathi Finance andInvestment Company Private Limited, Mr. Madhusudan Kabraand, Mr. Kishor laxminarayan Rathi (The selling shareholders) aggregating to Rs. [*] crores (The offer for sale). The issue comprises a reservation of upto 1,00,000 equity shares for subscription by eligible employees (The Employee Reservation Portion). The net issue will constitute 25% of the fully diluted post issue paid-up capital of the company.Price Band: Rs. [*] to Rs. [*] per equity share of face value of Rs. 10/- each.The floor price is [*] times of the face value and the cap price is [*] times of the face value.
Issue
Money Payable On
Further Multiples of: 0
Sun-Magnetica A Wing 5th Floor Nr LIC Service Rd Thane
Maharashtra- 400604
Phone - 91-22-41703200
Fax - 91-22-25835159
Email - info@enzymeindia.com
Website - www.enzymeindia.com